PFE
Pfizer Inc.
- Long-term debt, 2025
- $61.6B
- YoY, 2025
- +7.4%
- 5-year CAGR
- +10.7%
- 10-year CAGR
- +7.9%
Long-term debt
Long-term debt by fiscal year
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $61.6B | +7.4% |
| 2024 | $57.4B | −6.7% |
| 2023 | $61.5B | +87.1% |
| 2022 | $32.9B | −9.1% |
| 2021 | $36.2B | −2.5% |
| 2020 | $37.1B | +3.3% |
| 2019 | $36.0B | +9.3% |
| 2018 | $32.9B | −1.9% |
| 2017 | $33.5B | +6.8% |
| 2016 | $31.4B | +9.2% |
| 2015 | $28.7B | −8.9% |
| 2014 | $31.5B | +3.5% |
| 2013 | $30.5B | −1.8% |
| 2012 | $31.0B | −11.1% |
| 2011 | $34.9B | −9.1% |
| 2010 | $38.4B | −11.1% |
| 2009 | $43.2B | +442.4% |
| 2008 | $8.0B | — |